){kind=logo}
)
Mark Barber
Mark is a key member of AstraZeneca's AI Strategy & Innovation team, where he plays an important role in supporting R&D by guiding strategic decisions on AI investment and overseeing the delivery of custom AI technologies. With extensive experience in implementing AI solutions across diverse pharmaceutical functions, Mark brings a wealth of knowledge in this rapidly evolving landscape.
Before joining AstraZeneca, Mark served as a consultant, advising a variety of European pharmaceutical companies. He holds a PhD in Cellular Signalling from Cambridge University, contributing a deep understanding of the scientific foundations driving modern AI applications in healthcare. Mark's unique blend of strategic insight and technical expertise makes him an engaging and insightful speaker at AI summits.
-
11-Jun-2025Headliners StageAI in Science: Unlocking the World's Biggest Challenges
){kind=logo}
)
)
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
